Skip to content
On April 25, during the South Korean President’s state visit, the Biotechnology Innovation Organization (BIO) and KoreaBIO signed a bilateral Memorandum of Understanding (MOU) […]
KoreaBio signs MOU to advance the innovation of biotechnology Read More »
On Thursday, April 20, the Harvard Kennedy School’s Belfer Center for Science and International Affairs hosted “Initiating a Renaissance in Biosecurity Governance.” The hybrid
Harvard biosecurity event focuses on governance and emerging threats Read More »
If you are a regular reader of Bio.News, you likely know that the past two years have been difficult for the biotech market. Investor
As biotech market seeks rebound, economic and political environments are key Read More »
“Biotech in space” may sound like the title of an old sci-fi movie but the real-life partnership offers tantalizing potential, an I am BIO
I am BIO Podcast: Space station launches low-gravity biotech advances Read More »
The pace of biotech investment has slowed recently, harming development at the small, new companies that are driving innovation. “Coming down from the heyday
BIO webinar will advise biotech on weathering the slowing investor market Read More »
Gevo, a renewable chemicals and advanced biofuels company, announced a joint development agreement with LG Chem to develop sustainable bioplastics using proprietary ethanol-to-olefins (ETO)
Gevo announces joint development agreement with LG Chem on sustainable bioplastics Read More »
After weeks of tension, the Supreme Court decided mifepristone can stay… for now. On the evening of April 21, the Supreme Court ruled the
Supreme Court says mifepristone can stay – for now Read More »
With an upsurge in sexually transmitted infections (STIs) as well as the threat of antimicrobial resistance (AMR), the U.S. must take essential action to
U.S. surge in STIs threatens to converge with antimicrobial resistance Read More »
The American Association for Cancer Research (AACR) hosted its 114th annual meeting in Florida in April. Scientists, medical professionals, and many others came together
5 new discoveries at the American Association for Cancer Research annual meeting Read More »
Americans are rightly anxious about the increasing prevalence of serious and deadly infections associated with drug-resistant pathogens – also known as antimicrobial resistance (AMR).
We’re losing the fight against superbugs. The time to act is now. Read More »
